Unknown

Dataset Information

Clinical challenges in interpreting multiple pathogenic mutations in single patients.


ABSTRACT:

Background

In the past two decades, genetic testing for cancer risk assessment has entered mainstream clinical practice due to the availability of low-cost panels of multiple cancer-associated genes. However, the clinical value of multiple-gene panels for cancer susceptibility is not well established, especially in cases where panel testing identifies more than one pathogenic variant. The risk for specific malignancies as a result of a mutated gene is complex and likely influenced by superimposed modifier variants and/or environmental effects. Recent data suggests that the combination of multiple pathogenic variants may be fewer than reported by chance, suggesting that some mutation combinations may be detrimental. Management of patients with "incidentally" discovered mutations can

SUBMITTER: Slaught C 

PROVIDER: S-EPMC7863461 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature